PER 6.17% 8.6¢ percheron therapeutics limited

ANP a Company in the making., page-23

  1. 13,265 Posts.
    lightbulb Created with Sketch. 1409
    Read the last paragraph of my previous post...Mark Diamond ticks all the boxes...

    Mark Diamond
    Managing Director

    Mark Diamond has over 20 years’ experience in the pharmaceutical and biotechnology industry. Before joining Antisense Therapeutics Limited as MD and CEO in 2001, Mr. Diamond was employed in the US as Director, Project Planning/Business Development at Faulding Pharmaceuticals. Prior to this he held the positions of Senior Manager, Business Development and In-licensing within Faulding’s European operation based in the UK and International Business Development Manager with Faulding in Australia.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.6¢
Change
0.005(6.17%)
Mkt cap ! $77.53M
Open High Low Value Volume
8.2¢ 8.7¢ 8.2¢ $93.35K 1.100M

Buyers (Bids)

No. Vol. Price($)
1 228136 8.4¢
 

Sellers (Offers)

Price($) Vol. No.
8.6¢ 18794 1
View Market Depth
Last trade - 16.10pm 12/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.